Otsuka Signs Three-Year Collaboration with Holmusk to Enhance Digital Health and Data Analytics for Global Behavioral Health Programs
PRINCETON, N.J., July 7, 2021 /PRNewswire/ -- Otsuka Pharmaceutical Development & Commercialization, Inc. ("Otsuka"), announces today that it has entered a three-year collaboration with Holmusk Inc. ("Holmusk"), a global data science and digital health company building the world's largest real-world evidence (RWE) platform for behavioral health.
- PRINCETON, N.J., July 7, 2021 /PRNewswire/ -- Otsuka Pharmaceutical Development & Commercialization, Inc. ("Otsuka"), announces today that it has entered a three-year collaboration with Holmusk Inc. ("Holmusk"), a global data science and digital health company building the world's largest real-world evidence (RWE) platform for behavioral health.
- "Holmusk is a global leader in real-world evidence and owns distinctive data assets for behavioral health.
- As part of the collaboration, Otsuka's affiliate, Otsuka Pharmaceutical Europe Limited ("OPEL"), transferred its Otsuka Health Solutions (OHS) digital assets based in the U.K. to Holmusk.
- Holmusk uses advanced proprietary analytics to enrich the data, with Natural Language Processing and predictive disease models designed specifically for behavioral health.